Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells - Wikidata - thesis-toulmin - TriplyDB

Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells

Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells

http://www.wikidata.org/entity/Q28345246

about

PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings The Endocannabinoid System in the Postimplantation Period: A Role during Decidualization and Placentation Hub and switches: endocannabinoid signalling in midbrain dopamine neurons Endocannabinoids as Guardians of Metastasis Cannabinoids as therapeutic agents in cancer: current status and future implications Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: involvement of the CB2 receptor Increasing antiproliferative properties of endocannabinoids in N1E-115 neuroblastoma cells through inhibition of their metabolism.Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells.The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action.Behavioral effects of CB2 cannabinoid receptor activation and its influence on food and alcohol consumption.Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.Quantification of anandamide, oleoylethanolamide and palmitoylethanolamide in rodent brain tissue using high performance liquid chromatography-electrospray mass spectroscopy.Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study).Regulation of circulating endocannabinoids associated with cancer and metastases in mice and humans.Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.The expanding field of cannabimimetic and related lipid mediators.Cannabinoids and cancer: pros and cons of an antitumour strategy.The endocannabinoid system and cancer: therapeutic implication.Cellular viability effects of fatty acid amide hydrolase inhibition on cerebellar neurons Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner.Evaluation of fatty acid amides in the carrageenan-induced paw edema model.The complications of promiscuity: endocannabinoid action and metabolism Mustard vesicants alter expression of the endocannabinoid system in mouse skin.Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities.Changes in the endocannabinoid system may give insight into new and effective treatments for cancer.The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels.Targeted treatment of pruritus: a look into the future Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoid-neurotrophin interactions.The Endocannabinoid System and its Modulation by Phytocannabinoids.Dendritic Cell Regulation by Cannabinoid-Based Drugs Metabolic differentiation of early Lyme disease from southern tick-associated rash illness (STARI).N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia.Endocannabinoids and the processing of value-related signals A saturated N-acylethanolamine other than N-palmitoyl ethanolamine with anti-inflammatory properties: a neglected story...Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour.Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems.

P2860

Q21090748-183938FF-42C2-4625-B60D-A8F1B2454165 Q21284856-7F6FC1F3-CA10-43D6-8F61-1D7E18E099C2 Q24623244-92ECAA5E-BD3A-4FB3-86EC-7CF02F33E65A Q26766163-77BAF98A-3C5A-40E8-95C0-FB8694F37BFA Q26866298-53D24788-0FA2-48F2-AFCE-8E1482F1204C Q27305830-D1AFE135-45EF-4ED8-BD6A-B9EF98934920 Q28390536-944F2504-0940-4BCD-B261-8888B7BAE3D6 Q31122398-BAB3889E-5E6C-4D37-90B8-838293C9C929 Q33671206-6FFF4764-EA12-41DE-80A3-ECA5C4F396C1 Q34064728-6DCBEC55-19A0-43AC-BEBB-8D45DF081744 Q34128351-7704CFC2-939F-4326-8961-64E711AFD8E8 Q34202076-A2966E41-8B43-40EC-AA59-B89284B21F84 Q34451027-EDC65435-C8D4-43E8-AE17-C168B9243D04 Q34571380-39EA8483-2C1F-4D91-A83A-60CBFB9D7C57 Q34659846-EF581819-C207-47CB-BA4B-A371E4181C0A Q34734120-C12AB02E-6A7F-4F8F-AE6C-0B890FA0737F Q34781231-E230C35F-2A44-4E36-94B4-24CB7E7DE107 Q34795735-F56A9E13-73E5-49BE-A97F-042DB0FF9A4A Q35048658-8944A244-BFE8-4074-B901-F6D0CABD692E Q35100892-FC04C3F9-D707-4F31-A324-4AE688F2834F Q35193299-6D50C86C-44FE-47BC-A484-507CDA5CA2D8 Q35208884-5FB408F1-D644-426C-9259-E6006D1B64CA Q36027964-F4D8A1B8-E805-4F5C-89F5-75CDEDA56601 Q36384547-D399DBF6-B081-4328-A021-621FAC5FB3D1 Q36944706-A6DFB47E-98F8-487E-A63E-E218773D39CB Q37099962-E6459208-83FD-4689-8458-C8A32135E011 Q37219066-D0616EB7-2C55-4C45-AA39-D42887AA8185 Q37375986-1730652C-9B94-4E41-A7D7-CC798E4CC87F Q37568679-ABF97236-976C-426F-B5B1-44ACE8808E1C Q37682000-3E15EEED-FEA2-4A1D-8716-C590C47581E4 Q37827172-2D239AD4-1D03-4C01-A7B1-7D2C93FD89F8 Q38185071-226D5DE9-7234-4B81-AE93-96205502A1BE Q38566339-7E6A016C-63A2-45AB-8520-83350A522AF2 Q38974441-69273136-0116-4F75-857A-4AE7F5409C38 Q40091071-9B53BA28-86B0-49BB-AC2C-CCFD5FB027A4 Q40672731-6578B522-CEA3-4390-8438-001D3668F73A Q40794240-83E7FC42-8994-4C3E-A2C1-C56C1F485F24 Q42164486-57832297-6EE9-48A5-AC83-B489805C1FAE Q43975380-F2E25250-A459-4D7C-9C5C-E70C732F2B28 Q44304365-28AA59C0-C51D-40D2-B606-3FCD6B5E242E

P2860

Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells

http://www.wikidata.org/entity/Q28345246

description

2001 nî lūn-bûn

@nan

2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Palmitoylethanolamide inhibits ...... e in human breast cancer cells

@ast

Palmitoylethanolamide inhibits ...... e in human breast cancer cells

@en

Palmitoylethanolamide inhibits ...... e in human breast cancer cells

@nl

type

label

Palmitoylethanolamide inhibits ...... e in human breast cancer cells

@ast

Palmitoylethanolamide inhibits ...... e in human breast cancer cells

@en

Palmitoylethanolamide inhibits ...... e in human breast cancer cells

@nl

prefLabel

Palmitoylethanolamide inhibits ...... e in human breast cancer cells

@ast

Palmitoylethanolamide inhibits ...... e in human breast cancer cells

@en

Palmitoylethanolamide inhibits ...... e in human breast cancer cells

@nl

P1433

Q28345246-6BF7F900-15CB-4E74-A725-ECA12A6DA75C

P1476

Q28345246-81F21D7E-EF16-45A2-816B-CEC44C760858

P2093

Q28345246-2C07B98F-0155-442B-8E81-397E7CE34C07

Q28345246-442B4A26-4B08-4652-A103-AA4C698095D7

Q28345246-4E974CD3-BD0F-4940-AB45-E38218491852

Q28345246-8CA56A4E-0BF1-484B-98BC-1F09B35E1510

Q28345246-9CC5788A-9C43-4678-9015-608EEBDAC537

Q28345246-BEFA81D6-68EE-4326-87FF-E1F046031242

P2860

Q28345246-0AD9BC98-B861-4CF2-9C80-A30A33C52C49

Q28345246-15B301FD-8787-4B0A-AF49-F3E7C15F6A2C

Q28345246-18D5F5E4-944F-49F1-9413-E7DEC8404E36

Q28345246-19D60791-4810-495E-BE14-7CA2A1B2E76D

Q28345246-286D6D24-6518-48C3-B9E5-DEA641D47A13

Q28345246-292E767D-B5B9-4812-9731-4066048D91F3

Q28345246-2B07F534-A33F-4625-8BD2-041F5AE491AF

Q28345246-3CA73212-FA85-4D73-901A-F3B9B7E9D2F9

Q28345246-3E30B647-D9D6-4956-8D29-FA8D1B19AFAE

Q28345246-4040E1E0-A868-4379-ACF5-FC3D6A09D513

P304

Q28345246-1FFA05ED-A2B7-4C18-A8E8-3260258E8069

P31

Q28345246-935BD4FE-F669-4529-90E2-016B03C12CCE

P3181

Q28345246-51A31119-AD8A-4F79-87F7-9C0D76AAA706

P356

Q28345246-0C306E60-8AA5-42E0-B1F9-759F873A61AE

P407

Q28345246-99ABC641-57BF-4051-B6BE-E6949854C0BC

P433

Q28345246-17449E31-F845-4DA2-948A-B856DDD64844

P478

Q28345246-7603775E-642F-42D1-801D-668A490E8556

P50

Q28345246-4D7F1539-F3DB-413A-8617-9933ADF76F8D

Q28345246-CE998005-2D02-4F0B-A40B-6D0090884574

P577

Q28345246-D5C3E801-F35D-43B0-A56B-ABE9DA2DC8E6

P5875

Q28345246-F8DB1B47-CBF6-4651-8387-2A4E9C011867

P698

Q28345246-506AC16F-D81F-4F79-9676-EBBF78A15C9F

P921

Q28345246-530F5F09-7B41-46EF-B5DC-D31605F3DEDC

Q28345246-93C8B8E9-8C62-48CE-BF1E-893BDC0650AD

Q28345246-DFA5F88B-6AAB-4EB8-864F-EBAC0AB86506

P932

Q28345246-B101613F-4789-46CD-A8B9-BDFA85C68C1B

P3181

P356

0264-6021:3580249

P1433

Biochemical Journal

P1476

Palmitoylethanolamide inhibits ...... e in human breast cancer cells

@en

P2093

D Melck

http://www.w3.org/2001/XMLSchema#string

L De Petrocellis

http://www.w3.org/2001/XMLSchema#string

O Zagoory

http://www.w3.org/2001/XMLSchema#string

P Orlando

http://www.w3.org/2001/XMLSchema#string

T Bisogno

http://www.w3.org/2001/XMLSchema#string

Z Vogel

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and pharmacological characterization of the rat CB(2) cannabinoid receptor

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

Molecular characterization of a peripheral receptor for cannabinoids

Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide.

Use of potassium titanyl phosphate (KTP) laser in management of subglottic hemangiomas.

The palmitoylethanolamide and oleamide enigmas : are these two fatty acid amides cannabimimetic?

P304

249-255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1405551

http://www.w3.org/2001/XMLSchema#string

P356

10.1042/0264-6021:3580249

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 1

http://www.w3.org/2001/XMLSchema#string

P478

358

http://www.w3.org/2001/XMLSchema#string

P50

Vincenzo Di Marzo

Maurizio Bifulco

P577

2001-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11856785

http://www.w3.org/2001/XMLSchema#string

P698

11485574

http://www.w3.org/2001/XMLSchema#string

P921

P932

1222054

http://www.w3.org/2001/XMLSchema#string